Clinical trial Recruiting at 2 sites Interventional Ages 10 to 16

A program to reduce violence against girls in Pakistan through life skills education

Official title: Mainstreaming a Life Skills Education Programme Right to Play- Plus to Reduce Violence Against Girls in Pakistan

Run by Aga Khan University · NCT06777849 · Data updated 2026-11-12

This study is testing a program that teaches life skills to students in Pakistan to help reduce violence against girls by changing harmful social norms.

More Mental Health trials

Quick facts

Study typeInterventional
Ages10 Years to 16 Years
SexAll
Enrollment3000 (estimated)
SponsorAga Khan University
Academic / other
Locations2 sites (Karachi, Sindh and 1 other locations)
StatusRecruiting
StartedDecember 18, 2024
Main results expectedFebruary 2027
Study endsMay 2027
Registry record updatedJanuary 17, 2025
Trial IDNCT06777849 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this program are schools in District Malir and adjacent areas with a commitment to improving gender norms and student safety.

Probably not a fit

Schools that do not have the capacity or willingness to implement child protection measures and adapt to the program's requirements may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This initiative, known as Right to Play-Plus (RTP-Plus), aims to combat violence against women and girls by fostering changes in social norms among youth in schools. It utilizes a play-based learning methodology combined with a Life Skills Based Education curriculum to empower students to identify and prevent harmful gender norms. The program involves training teachers as key influencers and peer educators to effectively deliver a gender-transformative curriculum. The focus is on enhancing teachers' knowledge of sexual and reproductive health and rights while promoting a safe and supportive school environment.

Why it matters

Potential benefit: If successful, this program could significantly reduce violence against girls and improve gender equity in educational settings.

How similar studies have gone: Other studies have shown success with similar educational interventions aimed at reducing gender-based violence and promoting resilience among youth.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Schools will be chosen from District Malir and adjacent areas, including Korangi and East Karachi. Among the 100 selected schools, the following distribution will be maintained: 40 girls-only schools (public), 40 co-ed schools (private), and 20 boys-only schools (public).
* Schools having a minimum of 30 students enrolled in grade 6
* Private schools with low to medium fees, with monthly amounts ranging from PKR 2000 to 3500.
* Factors such as teacher availability, school management support, accessibility to research and intervention partners, and school clustering will also be considered for the selection of these hundred schools.
* Schools' willingness to adapt child protection and safeguarding/anti-harassment administrative measures and policies to improve school safety, reduce the use of corporal punishment, enhance school performance, and increase girls' retention rates, primarily apply to private schools.

Exclusion Criteria:

* Schools where Right to Play or Aahung have already implemented their play-based/other activities.

Where it's running

  • Korangi
    Karachi, Sindh, Pakistan
    Recruiting
  • Malir
    Karachi, Sindh, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.